180 related articles for article (PubMed ID: 6303563)
1. Characterization of an adenosine deaminase-deficient human histiocytic lymphoma cell line (DHL-9) and selection of mutants deficient in adenosir kinase and deoxycytidine kinase.
Kubota M; Kamatani N; Daddona PE; Carson DA
Cancer Res; 1983 Jun; 43(6):2606-10. PubMed ID: 6303563
[TBL] [Abstract][Full Text] [Related]
2. Differential production of deoxyadenosine by human T and B lymphoblasts.
Iizasa T; Kubota M; Carson DA
J Immunol; 1983 Oct; 131(4):1776-9. PubMed ID: 6352803
[TBL] [Abstract][Full Text] [Related]
3. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
Webster AD; Ip H; Pereira S
Clin Exp Immunol; 1982 Dec; 50(3):587-95. PubMed ID: 6299634
[TBL] [Abstract][Full Text] [Related]
4. Deoxynucleoside overproduction in deoxyadenosine-resistant, adenosine deaminase-deficient human histiocytic lymphoma cells.
Kubota M; Carrera CJ; Wasson DB; Carson DA
Biochim Biophys Acta; 1984 May; 804(1):37-43. PubMed ID: 6372866
[TBL] [Abstract][Full Text] [Related]
5. S-adenosylhomocysteine hydrolase inactivation and purine toxicity in cultured human T- and B-lymphoblasts.
Young GJ; Hallam LJ; Jack I; Van Der Weyden MB
J Lab Clin Med; 1984 Jul; 104(1):86-95. PubMed ID: 6330251
[TBL] [Abstract][Full Text] [Related]
6. Normal and mutant human adenosine deaminase genes.
Akeson AL; Wiginton DA; Hutton JJ
J Cell Biochem; 1989 Mar; 39(3):217-28. PubMed ID: 2651461
[TBL] [Abstract][Full Text] [Related]
7. An approach to a selection system for adenosine-deaminase-positive (ADA+) cells and detection of rat ADA+ "revertants".
Hirschhorn R; Ellenbogen A; Martiniuk F
J Cell Physiol; 1985 May; 123(2):277-82. PubMed ID: 3872305
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of adenosine deaminase-deficient human T cell lines.
Kohn DB; Mitsuya H; Ballow M; Selegue JE; Barankiewicz J; Cohen A; Gelfand E; Anderson WF; Blaese RM
J Immunol; 1989 Jun; 142(11):3971-7. PubMed ID: 2497184
[TBL] [Abstract][Full Text] [Related]
9. Identification of the mechanism of activation of 9-beta-D-arabinofuranosyladenine in human lymphoid cells using mutants deficient in nucleoside kinases.
Verhoef V; Sarup J; Fridland A
Cancer Res; 1981 Nov; 41(11 Pt 1):4478-83. PubMed ID: 6272978
[TBL] [Abstract][Full Text] [Related]
10. Adenosine kinase deficiency in tritiated deoxyadenosine-resistant mouse S49 lymphoma cell lines.
Sastry KJ; Huang C; Chan TS
Biochem Genet; 1987 Dec; 25(11-12):765-77. PubMed ID: 2835956
[TBL] [Abstract][Full Text] [Related]
11. Erythrocyte adenosine deaminase deficiency without immunodeficiency. Evidence for an unstable mutant enzyme.
Hirschhorn R; Roegner V; Jenkins T; Seaman C; Piomelli S; Borkowsky W
J Clin Invest; 1979 Oct; 64(4):1130-9. PubMed ID: 479373
[TBL] [Abstract][Full Text] [Related]
12. S-Adenosylhomocysteine hydrolase activity in a lymphoblastoid cell line from a patient with adenosine deaminase dificiency disease.
Tsuchiya S; Nakae S; Konno T; Tada K
J Inherit Metab Dis; 1981; 4(4):197-201. PubMed ID: 6796770
[TBL] [Abstract][Full Text] [Related]
13. Activation of deoxycytidine kinase by deoxyadenosine: implications in deoxyadenosine-mediated cytotoxicity.
Keszler G; Virga S; Spasokoukotskaja T; Bauer PI; Sasvari-Szekely M; Staub M
Arch Biochem Biophys; 2005 Apr; 436(1):69-77. PubMed ID: 15752710
[TBL] [Abstract][Full Text] [Related]
14. Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiency.
Agarwal RP; Crabtree GW; Parks RE; Nelson JA; Keightley R; Parkman R; Rosen FS; Stern RC; Polmar SH
J Clin Invest; 1976 Apr; 57(4):1025-35. PubMed ID: 947948
[TBL] [Abstract][Full Text] [Related]
15. Comparative characterization of B-lymphoblastoid cell lines in adenosine deaminase deficiency and its heterozygote.
Sawami H; Toyokawa Y; Ito K; Uchino H
Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):721-9. PubMed ID: 2618547
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of S49 mouse lymphoma cell mutants deficient in adenosine deaminase.
Chan TS; Huang C; Sato T
Somat Cell Mol Genet; 1989 Sep; 15(5):411-20. PubMed ID: 2789437
[TBL] [Abstract][Full Text] [Related]
17. Transfer of the adenosine deaminase (ADA) gene of a B-lymphoblastoid cell line (LCL) to an ADA-deficient LCL by a microcell-mediated chromosome transfer technique.
Sawami H; Ito K; Norioka M; Monden S; Fujita M; Uchino H
Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1033-44. PubMed ID: 2588953
[TBL] [Abstract][Full Text] [Related]
18. Expression of human adenosine deaminase in murine haematopoietic progenitor cells following retroviral transfer.
Belmont JW; Henkel-Tigges J; Chang SM; Wager-Smith K; Kellems RE; Dick JE; Magli MC; Phillips RA; Bernstein A; Caskey CT
Nature; 1986 Jul 24-30; 322(6077):385-7. PubMed ID: 3016551
[TBL] [Abstract][Full Text] [Related]
19. Adenosine metabolism in wild-type and enzyme-deficient variants of Chinese hamster ovary and Novikoff rat hepatoma cells.
Plagemann PG; Wohlhueter RM
J Cell Physiol; 1983 Aug; 116(2):236-46. PubMed ID: 6306018
[TBL] [Abstract][Full Text] [Related]
20. Plasma deoxyadenosine, adenosine, and erythrocyte deoxyATP are elevated at birth in an adenosine deaminase-deficient child.
Hirschhorn R; Roegner V; Rubinstein A; Papageorgiou P
J Clin Invest; 1980 Mar; 65(3):768-71. PubMed ID: 6965496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
